NEW YORK (GenomeWeb News) – Dubai, UAE-based Eastern Biotech said today that it has signed an agreement to promote Decode Genetics’ DNA-based tests for diabetes and other diseases in the Middle East.
 
The firm, which also runs a clinical reference lab, said that it would offer Decode’s tests for assessing risk of type 2 diabetes, myocardial infarction, atrial fibrillation, prostate cancer, glaucoma, breast cancer, and other tests currently under development by Decode.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.